Life insurance new product development continues to be negatively impacted by long lead times, both to generate ideas and bring them to market, and the perceived quality of innovation within these new ideas.
In mid-2014, RGA sought to assess and quantify these issues more closely by conducting its first global survey of life insurers.
In the United States, stroke was the fourth leading cause of death in 2013 and about 800,000 people are affected each year. In 2010, deaths due to ischemic strokes which can be attributed to high tobacco consumption accounted for more cases in Russia, China and India than in the rest of the world.
In coming years, expect to see more simplified and consumer-friendly products, including annuities tailored to young workers looking to build a nest egg. Life insurers’ back-office operations will also be better integrated, availing advisors of more cross-selling opportunities across product lines.
Here’s a scary thought: Many insurance companies are still using technology created decades ago — and for critical functions. Carriers are able to get necessary work accomplished, but are well behind other industries in terms of providing the level of service that customers increasingly demand in 2015.
In the 15 years since India reprivatised its insurance industry, several models have been developed to optimise operations, distribution, and suitability. Mr. Amit Punchhi of RGA examines the three elements that are contributing to the slowing down of the life market’s growth.
I am neither a clairvoyant nor in possession of a crystal ball. This confessed, after 45 years in life insurance risk assessment - and with an obsessive focus on tracking trends - I have some reasonably credible thoughts regarding how underwriting will be configured five years hence.
The proper assessment of current health is essential for underwriters to come to the best (and hopefully most aggressive) decision on policy pricing. This is straightforward when tests and current assessment of well being have been done by an attending physician and favorable results lead to standard and preferred issues. What about screening tests for health that assess risk and allow both the doctor and patient/insured to look for disease that isn’t currently causing symptoms?
Dementia is a topic that is aired with increasing frequency in the media – perhaps due to raised awareness but certainly as a response to demographic change. The subject also arises in the context of life and health insurance product development, underwriting and claims.
Shisha – the practice of smoking tobacco or non-tobacco alternatives in waterpipes – is becoming increasingly popular worldwide. Mr Devesh Anand of RGA Reinsurance Company Middle East Limited looks into the health risks of shisha and the underwriting considerations involved.